These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3309514)

  • 41. The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis.
    Bettinger DA; Yager DR; Diegelmann RF; Cohen IK
    Plast Reconstr Surg; 1996 Oct; 98(5):827-33. PubMed ID: 8823022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics.
    Polo M; Smith PD; Kim YJ; Wang X; Ko F; Robson MC
    Ann Plast Surg; 1999 Aug; 43(2):185-90. PubMed ID: 10454327
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models.
    Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S
    Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of keloid scars with a 1210-nm diode laser in an animal model.
    Philandrianos C; Bertrand B; Andrac-Meyer L; Magalon G; Casanova D; Kerfant N; Mordon S
    Lasers Surg Med; 2015 Dec; 47(10):798-806. PubMed ID: 26437851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts.
    Daian T; Ohtsuru A; Rogounovitch T; Ishihara H; Hirano A; Akiyama-Uchida Y; Saenko V; Fujii T; Yamashita S
    J Invest Dermatol; 2003 Jun; 120(6):956-62. PubMed ID: 12787120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth.
    Russell SB; Trupin KM; Rodríguez-Eaton S; Russell JD; Trupin JS
    Proc Natl Acad Sci U S A; 1988 Jan; 85(2):587-91. PubMed ID: 3422443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pathological genomics of keloid fibroblastic cells].
    Wang CM; Hyakusok H; Zhang QX; Yan L; Nakazawa N
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2005 Jul; 21(4):299-301. PubMed ID: 16248530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chondroitinase injection improves keloid pathology by reorganizing the extracellular matrix with regenerated elastic fibers.
    Ishiko T; Naitoh M; Kubota H; Yamawaki S; Ikeda M; Yoshikawa K; Fujita H; Yamaguchi H; Kurahashi Y; Suzuki S
    J Dermatol; 2013 May; 40(5):380-3. PubMed ID: 23451938
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential effects of hydrocortisone on both growth and collagen metabolism of human fibroblasts from normal and keloid tissue.
    Russell JD; Russell SB; Trupin KM
    J Cell Physiol; 1978 Nov; 97(2):221-9. PubMed ID: 701387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Morphological and morphometric analysis of the effects of intralesional tamoxifen on keloids.
    Soares-Lopes LR; Soares-Lopes IM; Filho LL; Alencar AP; da Silva BB
    Exp Biol Med (Maywood); 2017 May; 242(9):926-929. PubMed ID: 28440733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Keloids show regional distribution of proliferative and degenerate connective tissue elements.
    Bux S; Madaree A
    Cells Tissues Organs; 2010; 191(3):213-34. PubMed ID: 19641294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts.
    Meyer LJ; Russell SB; Russell JD; Trupin JS; Egbert BM; Shuster S; Stern R
    J Invest Dermatol; 2000 May; 114(5):953-9. PubMed ID: 10771477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conditioned medium from keloid keratinocyte/keloid fibroblast coculture induces contraction of fibroblast-populated collagen lattices.
    Mukhopadhyay A; Tan EK; Khoo YT; Chan SY; Lim IJ; Phan TT
    Br J Dermatol; 2005 Apr; 152(4):639-45. PubMed ID: 15840092
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
    Wu CS; Wu PH; Fang AH; Lan CC
    Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblasts.
    Thielitz A; Vetter RW; Schultze B; Wrenger S; Simeoni L; Ansorge S; Neubert K; Faust J; Lindenlaub P; Gollnick HP; Reinhold D
    J Invest Dermatol; 2008 Apr; 128(4):855-66. PubMed ID: 17943180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures.
    Tuan TL; Wu H; Huang EY; Chong SS; Laug W; Messadi D; Kelly P; Le A
    Am J Pathol; 2003 May; 162(5):1579-89. PubMed ID: 12707042
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth Differentiation Factor-9 Promotes Fibroblast Proliferation and Migration in Keloids through the Smad2/3 Pathway.
    Jiang Z; Yu Q; Xia L; Zhang Y; Wang X; Wu X; Gao Z
    Cell Physiol Biochem; 2016; 40(1-2):207-218. PubMed ID: 27855376
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reconstructed human keloid models show heterogeneity within keloid scars.
    Limandjaja GC; van den Broek LJ; Waaijman T; Breetveld M; Monstrey S; Scheper RJ; Niessen FB; Gibbs S
    Arch Dermatol Res; 2018 Dec; 310(10):815-826. PubMed ID: 30370495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic reprogramming in keloid fibroblasts: Aerobic glycolysis and a novel therapeutic strategy.
    Li Q; Qin Z; Nie F; Bi H; Zhao R; Pan B; Ma J; Xie X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):641-647. PubMed ID: 29337061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involution of keloid implants in athymic mice treated with pirfenidone or with triamcinolone.
    Shetlar MR; Shetlar DJ; Bloom RF; Shetlar CL; Margolin SB
    J Lab Clin Med; 1998 Dec; 132(6):491-6. PubMed ID: 9851739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.